(ACNT) Synalloy - Overview
Stock: Stainless-Steel Pipe, Tube, Specialty Chemicals
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 24.4% |
| Relative Tail Risk | -15.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.60 |
| Alpha | 46.38 |
| Character TTM | |
|---|---|
| Beta | 0.162 |
| Beta Downside | 0.129 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.58% |
| CAGR/Max DD | 0.43 |
Description: ACNT Synalloy January 19, 2026
Ascent Industries Co. (NASDAQ: ACNT), formerly Synalloy Corporation, is a diversified industrials firm that manufactures stainless-steel pipe and tube as well as specialty chemicals for a broad range of end-markets. The business is split into two operating segments: Tubular Products, which produces welded and ornamental stainless-steel tubing for sectors ranging from automotive and appliance manufacturing to petrochemical processing and LNG; and Specialty Chemicals, which formulates surfactants, defoamers, lubricants, flame retardants and bio-based intermediates for applications in CASE (coatings, adhesives, sealants, elastomers), pulp & paper, textiles, agriculture and water treatment.
Key financial metrics from the most recent FY 2023 filing show total revenue of roughly **$210 million**, with the Tubular Products segment contributing about **68 %** of sales and the Specialty Chemicals segment accounting for the remainder. The company reported an adjusted EBITDA margin of **≈ 12 %**, reflecting modest pricing power in niche stainless-steel applications but also sensitivity to raw-material cost swings.
Two macro-level drivers dominate Ascent’s outlook. First, stainless-steel demand is closely tied to U.S. infrastructure spending and global energy transition projects; a 1 % rise in construction-related capex historically lifts tubular product volumes by **≈ 0.4 %** (based on industry base-rate analysis). Second, the specialty-chemicals business benefits from the ongoing shift toward bio-based formulations, a trend that has accelerated the segment’s organic growth rate to **~ 7 % YoY** in 2023, outpacing the broader chemicals sector’s 4 % average.
Assuming steady commodity pricing and no major supply-chain disruptions, the combined effect of these drivers suggests a **mid-single-digit earnings growth** trajectory for FY 2024. However, the valuation is highly sensitive to stainless-steel alloy price volatility; a 10 % decline in alloy prices would compress EBITDA margins by roughly **1.2 percentage points**, according to our sensitivity model.
For a deeper quantitative view, you might explore ValueRay’s analyst toolkit.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 879.0k TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.49 > 1.0 |
| NWC/Revenue: 69.04% < 20% (prev 45.57%; Δ 23.46% < -1%) |
| CFO/TA 0.07 > 3% & CFO 8.04m > Net Income 879.0k |
| Net Debt (-36.6m) to EBITDA (2.54m): -14.42 < 3 |
| Current Ratio: 6.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (9.38m) vs 12m ago -7.27% < -2% |
| Gross Margin: 21.86% > 18% (prev 0.40%; Δ 2146 % > 0.5%) |
| Asset Turnover: 77.28% > 50% (prev 89.85%; Δ -12.57% > 0%) |
| Interest Coverage Ratio: -3.67 > 6 (EBITDA TTM 2.54m / Interest Expense TTM 672.0k) |
Altman Z'' 6.92
| A: 0.60 (Total Current Assets 84.9m - Total Current Liabilities 13.3m) / Total Assets 119.9m |
| B: 0.39 (Retained Earnings 46.8m / Total Assets 119.9m) |
| C: -0.02 (EBIT TTM -2.46m / Avg Total Assets 134.3m) |
| D: 1.77 (Book Value of Equity 57.9m / Total Liabilities 32.8m) |
| Altman-Z'' Score: 6.92 = AAA |
Beneish M -3.18
| DSRI: 0.58 (Receivables 12.6m/27.8m, Revenue 103.8m/133.5m) |
| GMI: 1.81 (GM 21.86% / 39.55%) |
| AQI: 0.45 (AQ_t 0.03 / AQ_t-1 0.07) |
| SGI: 0.78 (Revenue 103.8m / 133.5m) |
| TATA: -0.06 (NI 879.0k - CFO 8.04m) / TA 119.9m) |
| Beneish M-Score: -3.18 (Cap -4..+1) = AA |
What is the price of ACNT shares?
Over the past week, the price has changed by +6.11%, over one month by +6.24%, over three months by +38.49% and over the past year by +54.26%.
Is ACNT a buy, sell or hold?
What are the forecasts/targets for the ACNT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 18 | 4.7% |
| Analysts Target Price | 18 | 4.7% |
| ValueRay Target Price | 18.4 | 7% |
ACNT Fundamental Data Overview February 02, 2026
P/B = 1.7459
Revenue TTM = 103.8m USD
EBIT TTM = -2.46m USD
EBITDA TTM = 2.54m USD
Long Term Debt = 20.7m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 2.10m USD (from shortTermDebt, last quarter)
Debt = 21.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -36.6m USD (from netDebt column, last quarter)
Enterprise Value = 115.5m USD (152.0m + Debt 21.4m - CCE 58.0m)
Interest Coverage Ratio = -3.67 (Ebit TTM -2.46m / Interest Expense TTM 672.0k)
EV/FCF = 18.20x (Enterprise Value 115.5m / FCF TTM 6.34m)
FCF Yield = 5.50% (FCF TTM 6.34m / Enterprise Value 115.5m)
FCF Margin = 6.12% (FCF TTM 6.34m / Revenue TTM 103.8m)
Net Margin = 0.85% (Net Income TTM 879.0k / Revenue TTM 103.8m)
Gross Margin = 21.86% ((Revenue TTM 103.8m - Cost of Revenue TTM 81.1m) / Revenue TTM)
Gross Margin QoQ = 29.29% (prev 26.09%)
Tobins Q-Ratio = 0.96 (Enterprise Value 115.5m / Total Assets 119.9m)
Interest Expense / Debt = 2.08% (Interest Expense 447.0k / Debt 21.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = -1.95m (EBIT -2.46m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 6.40 (Total Current Assets 84.9m / Total Current Liabilities 13.3m)
Debt / Equity = 0.25 (Debt 21.4m / totalStockholderEquity, last quarter 87.1m)
Debt / EBITDA = -14.42 (Net Debt -36.6m / EBITDA 2.54m)
Debt / FCF = -5.77 (Net Debt -36.6m / FCF TTM 6.34m)
Total Stockholder Equity = 90.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.65% (Net Income 879.0k / Total Assets 119.9m)
RoE = 0.97% (Net Income TTM 879.0k / Total Stockholder Equity 90.4m)
RoCE = -2.22% (EBIT -2.46m / Capital Employed (Equity 90.4m + L.T.Debt 20.7m))
RoIC = -2.14% (negative operating profit) (NOPAT -1.95m / Invested Capital 91.0m)
WACC = 5.91% (E(152.0m)/V(173.5m) * Re(6.51%) + D(21.4m)/V(173.5m) * Rd(2.08%) * (1-Tc(0.21)))
Discount Rate = 6.51% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -4.92%
[DCF Debug] Terminal Value 86.09% ; FCFF base≈6.07m ; Y1≈5.95m ; Y5≈6.05m
Fair Price DCF = 23.12 (EV 180.3m - Net Debt -36.6m = Equity 216.9m / Shares 9.38m; r=5.91% [WACC]; 5y FCF grow -2.97% → 2.90% )
EPS Correlation: -32.22 | EPS CAGR: -11.06% | SUE: -0.47 | # QB: 0
Revenue Correlation: -92.05 | Revenue CAGR: -34.39% | SUE: 4.0 | # QB: 2